Found: 48
Select item for more details and to access through your institution.
Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 12, p. 1450, doi. 10.3390/ph15121450
- By:
- Publication type:
- Article
Aptamers in Bordeaux, 24-25 June 2016.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 1, p. 14, doi. 10.3390/ph10010014
- By:
- Publication type:
- Article
Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 5, p. 1734, doi. 10.1172/JCI62385
- By:
- Publication type:
- Article
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Von Willebrand factor targeted thrombolysis in canine basilar artery occlusion.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1436291
- By:
- Publication type:
- Article
Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 7, p. 606, doi. 10.1038/nbt.4153
- By:
- Publication type:
- Article
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 8, p. 1005, doi. 10.1038/nbt1223
- By:
- Publication type:
- Article
Antidote-mediated control of an anticoagulant aptamer in vivo.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 11, p. 1423, doi. 10.1038/nbt1023
- By:
- Publication type:
- Article
Notch Promotes Radioresistance of Glioma Stem Cells.
- Published in:
- Stem Cells, 2010, v. 28, n. 1, p. 17, doi. 10.1002/stem.261
- By:
- Publication type:
- Article
Development of universal antidotes to control aptamer activity.
- Published in:
- Nature Medicine, 2009, v. 15, n. 10, p. 1224, doi. 10.1038/nm.1990
- By:
- Publication type:
- Article
Antidote-Controlled Antithrombotic Therapy Targeting Factor IXa and Von Willebrand Factor.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1175, n. 1, p. 61, doi. 10.1111/j.1749-6632.2009.05017.x
- By:
- Publication type:
- Article
A Hybrid DNA Aptamer-Dendrimer Nanomaterial for Targeted Cell Labeling.
- Published in:
- Macromolecular Bioscience, 2009, v. 9, n. 9, p. 831, doi. 10.1002/mabi.200900046
- By:
- Publication type:
- Article
Ribozyme-mediated repair of defective mRNA by targeted trans-splicing.
- Published in:
- Nature, 1994, v. 371, n. 6498, p. 619, doi. 10.1038/371619a0
- By:
- Publication type:
- Article
Targeted Disruption of β-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093441
- By:
- Publication type:
- Article
Nucleic Acid Scavenging Polymers Inhibit Extracellular DNA-Mediated Innate Immune Activation without Inhibiting Anti-Viral Responses.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069413
- By:
- Publication type:
- Article
The Inhibition of Anti-DNA Binding to DNA by Nucleic Acid Binding Polymers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040862
- By:
- Publication type:
- Article
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2301, doi. 10.3390/cancers15082301
- By:
- Publication type:
- Article
An Aptamer for Broad Cancer Targeting and Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3217, doi. 10.3390/cancers12113217
- By:
- Publication type:
- Article
IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophages.
- Published in:
- PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245169
- By:
- Publication type:
- Article
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1116034
- By:
- Publication type:
- Article
H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity.
- Published in:
- Nucleic Acids Research, 2006, v. 34, n. 12, p. 3577
- By:
- Publication type:
- Article
Antithrombotic Therapy in Acute Coronary Syndrome: How Far Up the Coagulation Cascade Will We Go?
- Published in:
- Current Cardiology Reports, 2010, v. 12, n. 4, p. 315, doi. 10.1007/s11886-010-0117-6
- By:
- Publication type:
- Article
Colocalizing ribozymes with substrate rnas to increase their efficacy as gene inhibitors.
- Published in:
- Molecular Biotechnology, 1995, v. 54, n. 1-3, p. 57, doi. 10.1007/BF02787911
- By:
- Publication type:
- Article
RNA aptamers as reversible antagonists of coagulation factor IXa.
- Published in:
- Nature, 2002, v. 419, n. 6902, p. 90, doi. 10.1038/nature00963
- By:
- Publication type:
- Article
Emerging clinical applications of RNA.
- Published in:
- Nature, 2002, v. 418, n. 6894, p. 252, doi. 10.1038/418252a
- By:
- Publication type:
- Article
Rapidly Regulating Platelet Activity In Vivo With an Antidote Controlled Platelet Inhibitor.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 391, doi. 10.1038/mt.2011.226
- By:
- Publication type:
- Article
RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer Cells.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 1, p. 153, doi. 10.1038/mt.2008.235
- By:
- Publication type:
- Article
In Vivo Reprogramming of hTERT by Trans-splicing Ribozyme to Target Tumor Cells.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 1, p. 74, doi. 10.1038/sj.mt.6300282
- By:
- Publication type:
- Article
RNA Aptamer-targeted Inhibition of NF-κB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 1, p. 66, doi. 10.1038/sj.mt.6300320
- By:
- Publication type:
- Article
A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery.
- Published in:
- Molecular Therapy, 2006, v. 14, n. 3, p. 408, doi. 10.1016/j.ymthe.2006.04.006
- By:
- Publication type:
- Article
1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S395, doi. 10.1016/j.ymthe.2006.08.1123
- By:
- Publication type:
- Article
83. Cell-Type Specific Delivery of siRNAs with Aptamer-siRNA Chimeras.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S35, doi. 10.1016/j.ymthe.2006.08.101
- By:
- Publication type:
- Article
378. Retargeting Mobile Group II Introns to Repair Mutant Genes
- Published in:
- 2005
- By:
- Publication type:
- Abstract
377. Developing siRNAs to the E2Fs to Control Vascular Growth and Remodeling
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Retargeting mobile group II introns to repair mutant genes
- Published in:
- Molecular Therapy, 2005, v. 11, n. 5, p. 687, doi. 10.1016/j.ymthe.2005.01.014
- By:
- Publication type:
- Article
Ribozyme-Mediated Induction of Apoptosis in Human Cancer Cells by Targeted Repair of Mutant p53 RNA
- Published in:
- Molecular Therapy, 2004, v. 10, n. 2, p. 365, doi. 10.1016/j.ymthe.2004.05.007
- By:
- Publication type:
- Article
Optimizing Aptamer Activity for Gene Therapy Applications Using Expression Cassette SELEX
- Published in:
- Molecular Therapy, 2002, v. 6, n. 1, p. 30, doi. 10.1006/mthe.2002.0624
- By:
- Publication type:
- Article
Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses.
- Published in:
- Immunology, 2008, v. 125, n. 2, p. 229, doi. 10.1111/j.1365-2567.2008.02833.x
- By:
- Publication type:
- Article
The effect of surface contact activation and temperature on plasma coagulation with an RNA aptamer directed against factor IXa.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2013, v. 35, n. 1, p. 48, doi. 10.1007/s11239-012-0778-7
- By:
- Publication type:
- Article
The many faces of the contact pathway and their role in thrombosis.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2011, v. 32, n. 1, p. 9, doi. 10.1007/s11239-011-0578-5
- By:
- Publication type:
- Article
T-cell count and T-cell telomere length in patients with severe COVID-19.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1356638
- By:
- Publication type:
- Article
Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48211-6
- By:
- Publication type:
- Article
RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins
- Published in:
- FEBS Letters, 2004, v. 568, n. 1-3, p. 10, doi. 10.1016/j.febslet.2004.04.087
- By:
- Publication type:
- Article
Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor trafficking.
- Published in:
- Journal of Neurochemistry, 2009, v. 108, n. 1, p. 147, doi. 10.1111/j.1471-4159.2008.05748.x
- By:
- Publication type:
- Article
In vivo selection of tumor-targeting RNA motifs.
- Published in:
- Nature Chemical Biology, 2010, v. 6, n. 1, p. 22, doi. 10.1038/nchembio.277
- By:
- Publication type:
- Article
PEG‐Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response.
- Published in:
- Advanced Materials, 2022, v. 34, n. 10, p. 1, doi. 10.1002/adma.202107852
- By:
- Publication type:
- Article
PEG‐Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response.
- Published in:
- Advanced Materials, 2022, v. 34, n. 10, p. 1, doi. 10.1002/adma.202107852
- By:
- Publication type:
- Article
Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis.
- Published in:
- Biological Chemistry, 2009, v. 390, n. 2, p. 137, doi. 10.1515/BC.2009.022
- By:
- Publication type:
- Article